Supporting Cancer Survivors Following Treatment for Non-Hodgkin's and Hodgkin's Lymphoma: A Pilot Study Assessing the Feasibility and Process Outcomes of a Nurse-Led Intervention.

Spooner, AJ; Turner, J; Button, E; Yates, P; Kennedy, G; Butler, J; Bradford, N; Chan, A; Hart, NH; Chan, RJ

Supporting Cancer Survivors Following Treatment for Non-Hodgkin's and Hodgkin's Lymphoma: A Pilot Study Assessing the Feasibility and Process Outcomes of a Nurse-Led Intervention.

Spooner, AJ Turner, J Button, E Yates, P Kennedy, G Butler, J Bradford, N Chan, A Hart, NH Chan, RJ

Permalink

Publisher:: ELSEVIER SCIENCE INC
Publication Type:: Journal Article
Citation:: Semin Oncol Nurs, 2024, 40, (2), pp. 151592
Issue Date:: 2024-04

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published versionAdobe PDF (1.27 MB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Spooner, AJ
dc.contributor.author	Turner, J
dc.contributor.author	Button, E
dc.contributor.author	Yates, P
dc.contributor.author	Kennedy, G
dc.contributor.author	Butler, J
dc.contributor.author	Bradford, N
dc.contributor.author	Chan, A
dc.contributor.author	Hart, NH
dc.contributor.author	Chan, RJ
dc.date.accessioned	2025-01-10T04:20:08Z
dc.date.available	2024-01-23
dc.date.available	2025-01-10T04:20:08Z
dc.date.issued	2024-04
dc.identifier.citation	Semin Oncol Nurs, 2024, 40, (2), pp. 151592
dc.identifier.issn	0749-2081
dc.identifier.issn	1878-3449
dc.identifier.uri	http://hdl.handle.net/10453/183191
dc.description.abstract	OBJECTIVE: Lymphoma is the sixth most common cancer in Australia and comprises 2.8% of worldwide cancer diagnoses. Research targeting development and evaluation of post-treatment care for debilitating complications resulting from the disease and its treatment is limited. This study aimed to assess the feasibility and acceptability of a nurse-led survivorship intervention, post-treatment in Hodgkin's and non-Hodgkin's lymphoma survivors. METHODS: A single-center, prospective, 3-arm, pilot, randomized controlled, parallel-group trial was used. People with lymphoma were recruited and randomized to the intervention (ENGAGE), education booklet only, or usual care arm. Participants receiving ENGAGE received an educational booklet and were offered 3 consultations (via various modes) with a cancer nurse to develop a survivorship care plan and healthcare goals. Participant distress and intervention acceptability was measured at baseline and 12-wk. Acceptability was measured via a satisfaction survey using a 11-point scale. Feasibility was measured using participation, retention rates, and process outcomes. Data were analyzed using descriptive statistics. RESULTS: Thirty-four participants with HL and NHL were recruited to the study (11 = intervention, 11 = information only, 12 = usual care). Twenty-seven participants (79%) completed all time points from baseline to 12 wk. Seven (88%) of the 8 participants receiving ENGAGE completed all consultations using various modes to communicate with the nurse (videoconference 14/23, 61%; phone 5/23, 22%; face-to-face 4/23, 17%). Participants who completed the intervention were highly satisfied with ENGAGE. CONCLUSION: The ENGAGE intervention is feasible and highly acceptable for lymphoma survivors. These findings will inform a larger trial assessing effectiveness and cost effectiveness of ENGAGE.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	ELSEVIER SCIENCE INC
dc.relation.ispartof	Semin Oncol Nurs
dc.relation.isbasedon	10.1016/j.soncn.2024.151592
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	1110 Nursing, 1112 Oncology and Carcinogenesis
dc.subject.classification	Nursing
dc.subject.classification	3211 Oncology and carcinogenesis
dc.subject.classification	4205 Nursing
dc.subject.mesh	Humans
dc.subject.mesh	Pilot Projects
dc.subject.mesh	Female
dc.subject.mesh	Male
dc.subject.mesh	Cancer Survivors
dc.subject.mesh	Hodgkin Disease
dc.subject.mesh	Middle Aged
dc.subject.mesh	Feasibility Studies
dc.subject.mesh	Lymphoma, Non-Hodgkin
dc.subject.mesh	Prospective Studies
dc.subject.mesh	Adult
dc.subject.mesh	Australia
dc.subject.mesh	Aged
dc.subject.mesh	Oncology Nursing
dc.subject.mesh	Humans
dc.subject.mesh	Hodgkin Disease
dc.subject.mesh	Lymphoma, Non-Hodgkin
dc.subject.mesh	Prospective Studies
dc.subject.mesh	Feasibility Studies
dc.subject.mesh	Pilot Projects
dc.subject.mesh	Adult
dc.subject.mesh	Aged
dc.subject.mesh	Middle Aged
dc.subject.mesh	Australia
dc.subject.mesh	Female
dc.subject.mesh	Male
dc.subject.mesh	Oncology Nursing
dc.subject.mesh	Cancer Survivors
dc.subject.mesh	Humans
dc.subject.mesh	Pilot Projects
dc.subject.mesh	Female
dc.subject.mesh	Male
dc.subject.mesh	Cancer Survivors
dc.subject.mesh	Hodgkin Disease
dc.subject.mesh	Middle Aged
dc.subject.mesh	Feasibility Studies
dc.subject.mesh	Lymphoma, Non-Hodgkin
dc.subject.mesh	Prospective Studies
dc.subject.mesh	Adult
dc.subject.mesh	Australia
dc.subject.mesh	Aged
dc.subject.mesh	Oncology Nursing
dc.title	Supporting Cancer Survivors Following Treatment for Non-Hodgkin's and Hodgkin's Lymphoma: A Pilot Study Assessing the Feasibility and Process Outcomes of a Nurse-Led Intervention.
dc.type	Journal Article
utslib.citation.volume	40
utslib.location.activity	United States
utslib.for	1110 Nursing
utslib.for	1112 Oncology and Carcinogenesis
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Health
pubs.organisational-group	University of Technology Sydney/Faculty of Health/School of Sport, Exercise and Rehabilitation
pubs.organisational-group	University of Technology Sydney/UTS Groups
pubs.organisational-group	University of Technology Sydney/UTS Groups/Human Performance Research Centre (HPRC)
utslib.copyright.status	open_access	*
dc.rights.license	This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
dc.date.updated	2025-01-10T04:20:06Z
pubs.issue	2
pubs.publication-status	Published
pubs.volume	40
utslib.citation.issue	2

Abstract:

OBJECTIVE: Lymphoma is the sixth most common cancer in Australia and comprises 2.8% of worldwide cancer diagnoses. Research targeting development and evaluation of post-treatment care for debilitating complications resulting from the disease and its treatment is limited. This study aimed to assess the feasibility and acceptability of a nurse-led survivorship intervention, post-treatment in Hodgkin's and non-Hodgkin's lymphoma survivors. METHODS: A single-center, prospective, 3-arm, pilot, randomized controlled, parallel-group trial was used. People with lymphoma were recruited and randomized to the intervention (ENGAGE), education booklet only, or usual care arm. Participants receiving ENGAGE received an educational booklet and were offered 3 consultations (via various modes) with a cancer nurse to develop a survivorship care plan and healthcare goals. Participant distress and intervention acceptability was measured at baseline and 12-wk. Acceptability was measured via a satisfaction survey using a 11-point scale. Feasibility was measured using participation, retention rates, and process outcomes. Data were analyzed using descriptive statistics. RESULTS: Thirty-four participants with HL and NHL were recruited to the study (11 = intervention, 11 = information only, 12 = usual care). Twenty-seven participants (79%) completed all time points from baseline to 12 wk. Seven (88%) of the 8 participants receiving ENGAGE completed all consultations using various modes to communicate with the nurse (videoconference 14/23, 61%; phone 5/23, 22%; face-to-face 4/23, 17%). Participants who completed the intervention were highly satisfied with ENGAGE. CONCLUSION: The ENGAGE intervention is feasible and highly acceptable for lymphoma survivors. These findings will inform a larger trial assessing effectiveness and cost effectiveness of ENGAGE.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/183191